AdjuCor GmbH

AdjuCor is a high-tech medical device company that owns and is responsible for development, production, marketing and selling of a disruptive technology for the treatment of end-stage heart failure patients, namely BEAT. The market introduction of BEAT will render it the world’s first commercially available, minimal invasive application of mechanical circulatory support for the failing heart, that also completely avoids contacting the blood. This unique feature set will allow BEAT to transform the standard-of-care treatment in end-stage heart failure, as well as greatly expand treatment to previously unreached patients.